Table 2 Final list of screened SARS-CoV-2 specific neutralizing and therapeutic antibodies.
From: Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies
Neutralizing antibody | Therapeutic antibody | Sequence identity (%) | ||
|---|---|---|---|---|
Name | Length (aa) | Name | Length (aa) | |
C002 | 231 | Tremelimumab | 232 | 90 |
COV2-2015 | 230 | Afasevikumab | 231 | 92 |
COVA2-29 | 232 | Tremelimumab | 232 | 90 |
HbnC3t1p1_G4 | 224 | Ipilimumab | 226 | 90 |
